Login to Your Account

U.S. Supreme Court Takes Up Watson 'Pay-for-Delay' Case

By Staff Reports

Tuesday, December 11, 2012
The U.S. Supreme Court has agreed to hear arguments in a "pay-for-delay" case involving Watson Pharmaceuticals Inc., in which the Federal Trade Commission (FTC) claims Watson and other generic drugmakers violated the law by agreeing to accept $42 million for holding off the marketing of generic testosterone gels.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription